tiprankstipranks
Quince Therapeutics (QNCX)
NASDAQ:QNCX
US Market

Quince Therapeutics (QNCX) Income Statement

Compare
542 Followers

Quince Therapeutics Income Statement

Last quarter (Q3 2024), Quince Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Quince Therapeutics's net income was $-5.49M. See Quince Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -322.00K$ -175.00K$ -344.00K$ -332.00K$ -188.00K
Operating Expenses
$ 34.62M$ 51.19M$ 90.32M$ 78.89M$ 39.17M
Depreciation and Amortization
$ 322.00K$ 175.00K$ 344.00K$ 332.00K$ 188.00K
EBITDA
$ -31.26M$ -52.02M$ -89.97M$ -78.56M$ -38.98M
Operating Income
$ -34.62M$ -52.02M$ -90.32M$ -78.89M$ -39.17M
Other Income/Expenses
$ 3.04M$ 71.00K$ 373.00K$ 2.04M$ 2.19M
Pretax Income
$ -31.58M$ -51.94M$ -89.94M$ -76.85M$ -36.98M
Net Income
$ -31.39M$ -51.66M$ -89.33M$ -76.85M$ -36.79M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.84$ -1.54$ -3.01$ -2.63$ -1.93
Diluted EPS
$ -0.84$ -1.54$ -3.01$ -2.63$ -1.93
Weighted Average Shares Outstanding
37.24M 33.50M 29.72M 29.18M 19.03M
Weighted Average Shares Outstanding (Diluted)
37.24M 33.50M 29.72M 29.18M 19.03M
Currency in USD

Quince Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis